MedPath
NMPA Approval

Cinitapride Hydrogen Tartrate Tablets

H20160477

February 25, 2020

H20160477

Drug Information

酒石酸西尼必利片

希笛尼

希笛尼

片剂

1mg(按西尼必利计)

化学药品

February 25, 2020

February 24, 2025

Company Information

Applicant Company

Almirall, LLC

Ronda General Mitre, 151 08022 BARCELONA SPAIN

Manufacturing Company

industrias farmacéuticas almirall, s. a.

Ctra.de Martorell,41-61-08740 Sant Andreu de la Barca-Barcelona (Spain)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酒石酸西尼必利片 - NMPA 批准文号 | MedPath